Diagnostic and prognostic value of miR-1 and miR-29b on adverse ventricular remodeling after acute myocardial infarction - The SITAGRAMI-miR analysis.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  International Journal of Cardiology

• Publication date

  2017-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.ijcard.2017.06.054PMID 28663047
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Circulating endothelial microparticles and miR-92a in acute myocardial infarction

  2017cited by this paper
• Stability of Circulating Blood-Based MicroRNAs – Pre-Analytic Methodological Considerations

  2017cited by this paper
• Cardiac fibrosis in myocardial infarction—from repair and remodeling to regeneration

  2016cited by this paper
• Sitagliptin plus granulocyte colony-stimulating factor in patients suffering from acute myocardial infarction: A double-blind, randomized placebo-controlled trial of efficacy and safety (SITAGRAMI trial).

  2016cited by this paper
• MicroRNAs as Biomarkers for Acute Atrial Remodeling in Marathon Runners (The miRathon Study – A Sub-Study of the Munich Marathon Study)

  2016cited by this paper
• Combined therapy with sitagliptin plus granulocyte-colony stimulating factor in patients with acute myocardial infarction - Long-term results of the SITAGRAMI trial.

  2016cited by this paper
• Circulating MicroRNA-146a and MicroRNA-21 Predict Left Ventricular Remodeling after ST-Elevation Myocardial Infarction

  2015cited by this paper
• miR-29b as a therapeutic agent for angiotensin II-induced cardiac fibrosis by targeting TGF-β/Smad3 signaling.

  2014cited by this paper
• Smad3 Inactivation and MiR-29b Upregulation Mediate the Effect of Carvedilol on Attenuating the Acute Myocardium Infarction-Induced Myocardial Fibrosis in Rat

  2013cited by this paper
• MicroRNA29: A Mechanistic Contributor and Potential Biomarker in Atrial Fibrillation

  2013cited by this paper
• Inhibition of MicroRNA-92a Protects Against Ischemia/Reperfusion Injury in a Large-Animal Model

  2013cited by this paper
• Relationship Between the Temporal Profile of Plasma microRNA and Left Ventricular Remodeling in Patients After Myocardial Infarction

  2011cited by this paper
• Increased MicroRNA-1 and MicroRNA-133a Levels in Serum of Patients With Cardiovascular Disease Indicate Myocardial Damage

  2011cited by this paper
• Safety and efficacy of SITAgliptin plus GRanulocyte-colony-stimulating factor in patients suffering from Acute Myocardial Infarction (SITAGRAMI-Trial)--rationale, design and first interim analysis.

  2010cited by this paper
• Stress-dependent cardiac remodeling occurs in the absence of microRNA-21 in mice.

  2010cited by this paper
• Circulating microRNA: a novel potential biomarker for early diagnosis of acute myocardial infarction in humans.

  2010cited by this paper
• A translational study of circulating cell-free microRNA-1 in acute myocardial infarction.

  2010cited by this paper
• Circulating microRNAs are new and sensitive biomarkers of myocardial infarction

  2010cited by this paper
• Circulating microRNA-1 as a potential novel biomarker for acute myocardial infarction.

  2010cited by this paper
• MicroRNA expression in response to murine myocardial infarction: miR-21 regulates fibroblast metalloprotease-2 via phosphatase and tensin homologue.

  2009cited by this paper
• MicroRNA Expression Signature and the Role of MicroRNA-21 in the Early Phase of Acute Myocardial Infarction*

  2009cited by this paper
• Upregulated expression of miR-1/miR-206 in a rat model of myocardial infarction.

  2009cited by this paper
• Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis

  2008cited by this paper
• MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts

  2008cited by this paper
• The muscle-specific microRNAs miR-1 and miR-133 produce opposing effects on apoptosis by targeting HSP60, HSP70 and caspase-9 in cardiomyocytes

  2007cited by this paper
• Regenerating the heart

  2005cited by this paper

• miR-21 in cardiovascular disease: new insights and emerging therapeutic potential

  2025influential citation
• Beneficial and challenges of exosome application in ischemic heart disease

  2025cites this paper
• Circulating microRNA-1 as a diagnostic biomarker for acute myocardial infarction: a meta-analysis

  2025cites this paper
• A Systematic Review on Novel Biomarkers and Multiple-Marker Approach for Cardiovascular Diseases and their Clinical Applications

  2025cites this paper
• Harnessing DNA computing and nanopore decoding for practical applications: from informatics to microRNA-targeting diagnostics

  2024cites this paper
• Streptococcus gordonii Supragingival Bacterium Oral Infection-Induced Periodontitis and Robust miRNA Expression Kinetics

  2024cites this paper
• Identification of immune-related genes and small-molecule drugs in hypertension-induced left ventricular hypertrophy based on machine learning algorithms and molecular docking

  2024cites this paper
• Circulating miRNA-21 as early potential diagnostic biomarker for acute myocardial infarction: a meta-analysis

  2024cites this paper
• MICRORNAS COMO BIOMARCADORES EM DOENÇAS CARDIOVASCULARES

  2024cites this paper
• Differential gene expression patterns in ST-elevation Myocardial Infarction and Non-ST-elevation Myocardial Infarction

  2024cites this paper
• Sevoflurane exerts protection against myocardial ischemia-reperfusion injury and pyroptosis through the circular RNA PAN3/microRNA-29b-3p/stromal cell-derived factor 4 axis.

  2023cites this paper
• New Biomarkers for Cardiovascular Disease

  2023cites this paper
• Influence and mechanism of sodium-glucose cotransporter-2 inhibitors on the cardiac function: study protocol for a prospective cohort study

  2023cites this paper
• Clinical Variables Influence the Ability of miR-101, miR-150, and miR-21 to Predict Ventricular Remodeling after ST-Elevation Myocardial Infarction

  2023cites this paper
• Characterization of Systemic and Culprit-Coronary Artery miR-483-5p Expression in Chronic CAD and Acute Myocardial Infarction Male Patients

  2023cites this paper
• MicroRNA regulation of phenotypic transformations in vascular smooth muscle: relevance to vascular remodeling

  2023cites this paper
• Functional Role of microRNAs in Regulating Cardiomyocyte Death

  2022cites this paper
• MicroRNAs as Potential Biomarkers in Coronary Artery Disease

  2022cites this paper
• Clinical Application of Serum microRNAs in Atherosclerotic Coronary Artery Disease

  2022cites this paper
• Prioritization of microRNA biomarkers for a prospective evaluation in a cohort of myocardial infarction patients based on their mechanistic role using public datasets

  2022cites this paper
• A systematic review of miRNAs as biomarkers for chemotherapy-induced cardiotoxicity in breast cancer patients reveals potentially clinically informative panels as well as key challenges in miRNA research

  2022cites this paper
• Therapeutic properties of stem cell-derived exosomes in ischemic heart disease.

  2022cites this paper
• Restoring Ravaged Heart: Molecular Mechanisms and Clinical Application of miRNA in Heart Regeneration

  2022cites this paper
• Usefullness of MicroRNAs in Predicting the Clinical Outcome of Patients with Acute Myocardial Infarction During Follow-Up: A Systematic Review

  2022cites this paper
• Insights Into Platelet-Derived MicroRNAs in Cardiovascular and Oncologic Diseases: Potential Predictor and Therapeutic Target

  2022cites this paper
• Circulating biomarkers as predictors of left ventricular remodeling after myocardial infarction

  2021cites this paper
• Role of the microRNA-29 family in myocardial fibrosis

  2021cites this paper
• Diagnostic and Prognostic Value of miRNAs after Coronary Artery Bypass Grafting: A Review

  2021influential citation
• MicroRNAs—The Heart of Post-Myocardial Infarction Remodeling

  2021influential citation
• miR-21 and miR-146a: the microRNAs of inflammaging and age-related diseases.

  2021cites this paper
• Potential clinical applications of exosomes in the diagnosis, treatment, and prognosis of cardiovascular diseases: a narrative review

  2021cites this paper
• MicroRNAs in Acute ST Elevation Myocardial Infarction—A New Tool for Diagnosis and Prognosis: Therapeutic Implications

  2021cites this paper
• MicroRNAs: New Biomarkers for the progression of Coronary Artery Diseases

  2020cites this paper
• MicroRNAs as potential biomarkers in congenital heart surgery.

  2020cites this paper
• Value of circulating miRNA-1 detected within 3 h after the onset of acute chest pain in the diagnosis and prognosis of acute myocardial infarction.

  2020cites this paper
• Trimethylamine-N-oxide has prognostic value in coronary heart disease: a meta-analysis and dose-response analysis

  2020cites this paper
• Challenges in Using Circulating Micro-RNAs as Biomarkers for Cardiovascular Diseases

  2020influential citation
• MicroRNA and Cardiovascular Diseases

  2020cites this paper
• MiR-101 attenuates myocardial infarction-induced injury by targeting DDIT4 to regulate autophagy.

  2020cites this paper
• Noncoding RNAs as Biomarkers for Acute Coronary Syndrome

  2020cites this paper
• Definition of left ventricular remodelling following ST-elevation myocardial infarction: a systematic review of cardiac magnetic resonance studies in the past decade

  2020cites this paper
• Non-coding RNAs - Update on mechanisms and therapeutic targets from the ESC Working Groups of Myocardial Function and Cellular Biology of the Heart.

  2020cites this paper
• Circulating miR-1 as a potential predictor of left ventricular remodeling following acute ST-segment myocardial infarction using cardiac magnetic resonance.

  2020influential citation
• Circulating microRNA in Heart Failure—Practical Guidebook to Clinical Application

  2020cites this paper
• miR-1: A comprehensive review of its role in normal development and diverse disorders.

  2020cites this paper
• Potential Roles of MyomiRs in Cardiac Development and Related Diseases

  2020cites this paper
• High-fructose drinks affect microRNAs expression differently in lean and obese mice.

  2019cites this paper
• The relevance of microRNA in post-infarction left ventricular remodelling and heart failure

  2019cites this paper
• The circulating HOTAIR/miR-1: A novel and sensitive biomarker of myocardial infarction.

  2019cites this paper
• MicroRNAs as Prognostic Markers in Acute Coronary Syndrome Patients—A Systematic Review

  2019cites this paper
• Applications of miRNAs in cardiac development, disease progression and regeneration

  2019cites this paper
• Metoprolol protects against myocardial infarction by inhibiting miR‐1 expression in rats

  2019influential citation
• Differential chamber-specific expression and regulation of long non-coding RNAs during cardiac development.

  2019cites this paper
• Circulating microRNA-1 in the diagnosis and predicting prognosis of patients with chest pain: a prospective cohort study

  2019cites this paper
• Epigenetic Biomarkers in Cardiovascular Diseases

  2019cites this paper
• MicroRNA-150 alleviates acute myocardial infarction through regulating cardiac fibroblasts in ventricular remodeling.

  2019cites this paper
• Circulating MicroRNAs as Novel Potential Biomarkers for Left Ventricular Remodeling in Postinfarction Heart Failure

  2019cites this paper
• Initial Concentrations of miR-1 MicroRNA Precursor and High-Sensitivity Troponin in the Diagnosis of Non-ST Myocardial Infarction among Patients with and Those without Chronic Kidney Disease

  2019cites this paper
• Circulating microRNAs to predict heart failure after acute myocardial infarction in women.

  2019cites this paper
• In depth understanding of adverse ventricular remodeling after acute myocardial infarction.

  2018cites this paper
• Biomarqueurs transcriptomiques sanguins des maladies cardiovasculaires

  2018cites this paper
• The circulating miRNAs as diagnostic and prognostic markers

  2018cites this paper
• Pathogenic effect of PI3K/Akt signaling inhibition by miR-1 and miR-29b on adverse post-infarct ventricular remodeling.

  2018cites this paper
• LncRNA H19 regulates cardiomyocyte apoptosis and acute myocardial infarction by targeting miR-29b.

  2018cites this paper
• miRNAS in cardiovascular diseases: potential biomarkers, therapeutic targets and challenges

  2018cites this paper
• MicroRNAs in acute myocardial infarction: Evident value as novel biomarkers?

  2018cites this paper
• Identification of microRNAs as potential cellular monocytic biomarkers in the early phase of myocardial infarction: a pilot study

  2017cites this paper